Home » Topics » Regulatory » Patents

Patents
RSS

Tricyclic antiproliferative agents revealed by Schering-Plough

Jan. 19, 1999

Novel antidiabetic agents in development at Novo Nordisk

Jan. 18, 1999

Research at Jouveinal leads to potent and selective PDE4 inhibitors

Jan. 18, 1999

More PDE5 inhibitors in the Pfizer pipeline

Jan. 18, 1999

Takeda develops compounds that induce and/or enhance cell differentiation

Jan. 18, 1999

Selective dopamine D3 receptor modulators synthesized at SB

Jan. 18, 1999

SmithKline Beecham describes novel compounds for depression and other CNS disorders

Jan. 18, 1999

Dopamine D3 antagonists for psychoses and other D3 ligands designed at SmithKline Beecham

Jan. 15, 1999

Urea derivatives acting at multiple 5-HT receptor subtypes emerge from SB R&D

Jan. 15, 1999

Agouron's new MMP inhibitors described in patent literature

Jan. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026